Studies have reported that calycosin can relive sepsis-induced acute lung injury (ALI) by inhibiting the HMGB1/myeloid differentiation factor 88 (MyD88)/NF-κB pathway and activating the NLRP3 inflammasome. The gene discussed is HMGB1; the disease is Sepsis.